DNA demethylation
DNA demethylation
Main page
1159123

DNA demethylation

logo
Community Hub0 subscribers
Read side by side
from Wikipedia
DNA methylation is the addition of a methyl group to the DNA that happens at cytosine. The image shows a cytosine single ring base and a methyl group added on to the 5 carbon. In mammals, DNA methylation occurs almost exclusively at a cytosine that is followed by a guanine.

For molecular biology in mammals, DNA demethylation causes replacement of 5-methylcytosine (5mC) in a DNA sequence by cytosine (C) (see figure of 5mC and C). DNA demethylation can occur by an active process at the site of a 5mC in a DNA sequence or, in replicating cells, by preventing addition of methyl groups to DNA so that the replicated DNA will largely have cytosine in the DNA sequence (5mC will be diluted out).

Methylated cytosine is frequently present in the linear DNA sequence where a cytosine is followed by a guanine in a 5' → 3' direction (a CpG site). In mammals, DNA methyltransferases (which add methyl groups to DNA bases) exhibit a strong sequence preference for cytosines at CpG sites.[1] There appear to be more than 20 million CpG dinucleotides in the human genome (see genomic distribution). In mammals, on average, 70% to 80% of CpG cytosines are methylated,[2] though the level of methylation varies with different tissues. Methylated cytosines often occur in groups or CpG islands within the promoter regions of genes, where such methylation may reduce or silence gene expression (see gene expression). Methylated cytosines in the gene body, however, are positively correlated with expression.[3]

Almost 100% DNA demethylation occurs by a combination of passive dilution and active enzymatic removal during the reprogramming that occurs in early embryogenesis and in gametogenesis. Another large demethylation, of about 3% of all genes, can occur by active demethylation in neurons during formation of a strong memory.[4] After surgery, demethylations are found in peripheral blood mononuclear cells at sites annotated to immune system genes.[5] Demethylations also occur during the formation of cancers.[6] During global DNA hypomethylation of tumor genomes, there is a minor to moderate reduction of the number of methylated cytosines (5mC) amounting to a loss of about 5% to 20% on average of the 5mC bases.[7]

Embryonic development

[edit]
Methylation levels during mouse early embryonic development.

Early embryonic development

[edit]

The mouse sperm genome is 80–90% methylated at its CpG sites in DNA, amounting to about 20 million methylated sites.[citation needed] After fertilization, the paternal chromosome is almost completely demethylated in six hours by an active process, before DNA replication (blue line in Figure).

Demethylation of the maternal genome occurs by a different process. In the mature oocyte, about 40% of its CpG sites in DNA are methylated. While somatic cells of mammals have three main DNA methyltransferases (which add methyl groups to cytosines at CpG sites), DNMT1, DNMT3A, and DNMT3B, in the pre-implantation embryo up to the blastocyst stage (see Figure), the only methyltransferase present is an isoform of DNMT1 designated DNMT1o.[8] DNMT1o has an alternative oocyte-specific promoter and first exon (exon 1o) located 5' of the somatic and spermatocyte promoters. As reviewed by Howell et al.,[8] DNMT1o is sequestered in the cytoplasm of mature oocytes and in 2-cell and 4-cell embryos, but at the 8-cell stage is only present in the nucleus. At the 16 cell stage (the morula) DNMT1o is again found only in the cytoplasm. It appears that demethylation of the maternal chromosomes largely takes place by blockage of the methylating enzyme DNMT1o from entering the nucleus except briefly at the 8 cell stage. The maternal-origin DNA thus undergoes passive demethylation by dilution of the methylated maternal DNA during replication (red line in Figure). The morula (at the 16 cell stage), has only a small amount of DNA methylation (black line in Figure).

DNMT3b begins to be expressed in the blastocyst.[9] Methylation begins to increase at 3.5 days after fertilization in the blastocyst, and a large wave of methylation then occurs on days 4.5 to 5.5 in the epiblast, going from 12% to 62% methylation, and reaching maximum level after implantation in the uterus.[10] By day seven after fertilization, the newly formed primordial germ cells (PGC) in the implanted embryo segregate from the remaining somatic cells. At this point the PGCs have about the same level of methylation as the somatic cells.

Gametogenesis

[edit]

The newly formed primordial germ cells (PGC) in the implanted embryo devolve from the somatic cells. At this point the PGCs have high levels of methylation. These cells migrate from the epiblast toward the gonadal ridge. As reviewed by Messerschmidt et al.,[11] the majority of PGCs are arrested in the G2 phase of the cell cycle, while they migrate toward the hindgut during embryo days 7.5 to 8.5. Then demethylation of the PGCs takes place in two waves.[11] At day 9.5 the primordial germ cells begin to rapidly replicate going from about 200 PGCs at embryo day 9.5 to about 10,000 PGCs at day 12.5.[12] During days 9.5 to 12.5 DNMT3a and DNMT3b are repressed and DNMT1 is present in the nucleus at a high level. But DNMT1 is unable to methylate cytosines during days 9.5 to 12.5 because the UHRF1 gene (also known as NP95) is repressed and UHRF1 is an essential protein needed to recruit DNMT1 to replication foci where maintenance DNA methylation takes place.[12] This is a passive, dilution form of demethylation.

In addition, from embryo day 9.5 to 13.5 there is an active form of demethylation. As indicated below in "Molecular stages of active reprogramming," two enzymes are central to active demethylation. These are a ten-eleven translocation methylcytosine dioxygenase (TET) and thymine-DNA glycosylase (TDG). One particular TET enzyme, TET1, and TDG are present at high levels from embryo day 9.5 to 13.5,[12] and are employed in active demethylation during gametogenesis.[11] PGC genomes display the lowest levels of DNA methylation of any cells in the entire life cycle of the mouse at embryonic day 13.5.[13]

Learning and Memory

[edit]
Brain regions involved in memory formation

Learning and memory have levels of permanence, differing from other mental processes such as thought, language, and consciousness, which are temporary in nature. Learning and memory can be either accumulated slowly (multiplication tables) or rapidly (touching a hot stove), but once attained, can be recalled into conscious use for a long time. Rats subjected to one instance of contextual fear conditioning create an especially strong long-term memory. At 24 hours after training, 9.17% of the genes in the genomes of rat hippocampus neurons were found to be differentially methylated. This included more than 2,000 differentially methylated genes at 24 hours after training, with over 500 genes being demethylated.[4] Similar results to that in the rat hippocampus were also obtained in mice with contextual fear conditioning.[14]

The hippocampus region of the brain is where contextual fear memories are first stored (see figure of the brain, this section), but this storage is transient and does not remain in the hippocampus. In rats contextual fear conditioning is abolished when the hippocampus is subjected to hippocampectomy just one day after conditioning, but rats retain a considerable amount of contextual fear when hippocampectomy is delayed by four weeks.[15] In mice, examined at 4 weeks after conditioning, the hippocampus methylations and demethylations were reversed (the hippocampus is needed to form memories but memories are not stored there) while substantial differential CpG methylation and demethylation occurred in cortical neurons during memory maintenance. There were 1,223 differentially methylated genes in the anterior cingulate cortex of mice four weeks after contextual fear conditioning. Thus, while there were many methylations in the hippocampus shortly after memory was formed, all these hippocampus methylations were demethylated as soon as four weeks later.

Demethylation in Cancer

[edit]

The human genome contains about 28 million CpG sites, and roughly 60% of the CpG sites are methylated at the 5 position of the cytosine.[16] During formation of a cancer there is an average reduction of the number of methylated cytosines of about 5% to 20%,[7] or about 840,00 to 3.4 million demethylations of CpG sites.

DNMT1 methylates CpGs on hemi-methylated DNA during DNA replication. Thus, when a DNA strand has a methylated CpG, and the newly replicated strand during semi-conservative replication lacks a methyl group on the complementary CpG, DNMT1 is normally recruited to the hemimethylated site and adds a methyl group to cytosine in the newly synthesized CpG. However, recruitment of DNMT1 to hemimethylated CpG sites during DNA replication depends on the UHRF1 protein. If UHRF1 does not bind to a hemimethylated CpG site, then DNMT1 is not recruited and cannot methylate the newly synthesized CpG site. The arginine methyltransferase PRMT6 regulates DNA methylation by methylating the arginine at position 2 of histone 3 (H3R2me2a).[17] (See Protein methylation#Arginine.) In the presence of H3R2me2a UHRF1 can not bind to a hemimethylated CpG site, and then DNMT1 is not recruited to the site, and the site remains hemimethylated. Upon further rounds of replication the methylated CpG is passively diluted out. PRMT6 is frequently overexpressed in many types of cancer cells.[18] The overexpression of PRMT6 may be a source of DNA demethylation in cancer.

Molecular stages of active reprogramming

[edit]

Three molecular stages are required for actively, enzymatically reprogramming the DNA methylome. Stage 1: Recruitment. The enzymes needed for reprogramming are recruited to genome sites that require demethylation or methylation. Stage 2: Implementation. The initial enzymatic reactions take place. In the case of methylation, this is a short step that results in the methylation of cytosine to 5-methylcytosine. Stage 3: Base excision DNA repair. The intermediate products of demethylation are catalysed by specific enzymes of the base excision DNA repair pathway that finally restore cystosine in the DNA sequence.

Stage 2 of active demethylation

[edit]
Demethylation of 5-methylcytosine. Demethylation of 5-methylcytosine (5mC) in neuron DNA. As reviewed in 2018,[19] in brain neurons, 5mC is oxidized by a TET dioxygenase to generate 5-hydroxymethylcytosine (5hmC). In successive steps a TET enzyme further hydroxylates 5hmC to generate 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). Thymine-DNA glycosylase (TDG) recognizes the intermediate bases 5fC and 5caC and cleaves the glycosidic bond resulting in an apyrimidinic site (AP site). In an alternative oxidative deamination pathway, 5hmC can be oxidatively deaminated by activity-induced cytidine deaminase/apolipoprotein B mRNA editing complex (AID/APOBEC) to form 5-hydroxymethyluracil (5hmU). 5mC can also be converted to thymine (Thy). 5hmU can be cleaved by TDG, single-strand-selective monofunctional uracil-DNA glycosylase 1 (SMUG1), Nei-Like DNA glycosylase 1 (NEIL1), or methyl-CpG binding protein 4 (MBD4). AP sites and T:G mismatches are then repaired by base excision repair (BER) enzymes to yield cytosine (Cyt).

Demethylation of 5-methylcytosine to generate 5-hydroxymethylcytosine (5hmC) very often initially involves oxidation of 5mC (see Figure in this section) by ten-eleven translocation methylcytosine dioxygenases (TET enzymes).[20] The molecular steps of this initial demethylation are shown in detail in TET enzymes. In successive steps (see Figure) TET enzymes further hydroxylate 5hmC to generate 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). Thymine-DNA glycosylase (TDG) recognizes the intermediate bases 5fC and 5caC and excises the glycosidic bond resulting in an apyrimidinic site (AP site). This is followed by base excision repair (stage 3). In an alternative oxidative deamination pathway, 5hmC can be oxidatively deaminated by APOBEC (AID/APOBEC) deaminases to form 5-hydroxymethyluracil (5hmU). Also, 5mC can be converted to thymine (Thy). 5hmU can be cleaved by TDG, MBD4, NEIL1 or SMUG1. AP sites and T:G mismatches are then repaired by base excision repair (BER) enzymes to yield cytosine (Cyt). The TET family of dioxygenases are employed in the most frequent type of demethylation reactions.[20]

TET family

[edit]

TET dioxygenase isoforms include at least two isoforms of TET1, one of TET2 and three isoforms of TET3.[21][22] The full-length canonical TET1 isoform appears virtually restricted to early embryos, embryonic stem cells and primordial germ cells (PGCs). The dominant TET1 isoform in most somatic tissues, at least in the mouse, arises from alternative promoter usage which gives rise to a short transcript and a truncated protein designated TET1s. The isoforms of TET3 are the full length form TET3FL, a short form splice variant TET3s, and a form that occurs in oocytes and neurons designated TET3o. TET3o is created by alternative promoter use and contains an additional first N-terminal exon coding for 11 amino acids. TET3o only occurs in oocytes and neurons and is not expressed in embryonic stem cells or in any other cell type or adult mouse tissue tested. Whereas TET1 expression can barely be detected in oocytes and zygotes, and TET2 is only moderately expressed, the TET3 variant TET3o shows extremely high levels of expression in oocytes and zygotes, but is nearly absent at the 2-cell stage. It is possible that TET3o, high in neurons, oocytes and zygotes at the one cell stage, is the major TET enzyme utilized when very large scale rapid demethylations occur in these cells.

Stage 1 of demethylation - recruitment of TET to DNA

[edit]

The TET enzymes do not specifically bind to 5-methylcytosine except when recruited. Without recruitment or targeting, TET1 predominantly binds to high CG promoters and CpG islands (CGIs) genome-wide by its CXXC domain that can recognize un-methylated CGIs.[23] TET2 does not have an affinity for 5-methylcytosine in DNA.[24] The CXXC domain of the full-length TET3, which is the predominant form expressed in neurons, binds most strongly to CpGs where the C was converted to 5-carboxycytosine (5caC). However, it also binds to un-methylated CpGs.[22]

Initiation of DNA demethylation at a CpG site. In adult somatic cells DNA methylation typically occurs in the context of CpG dinucleotides (CpG sites), forming 5-methylcytosine-pG, (5mCpG). Reactive oxygen species (ROS) may attack guanine at the dinucleotide site, forming 8-hydroxy-2'-deoxyguanosine (8-OHdG), and resulting in a 5mCp-8-OHdG dinucleotide site. The base excision repair enzyme OGG1 targets 8-OHdG and binds to the lesion without immediate excision. OGG1, present at a 5mCp-8-OHdG site recruits TET1 and TET1 oxidizes the 5mC adjacent to the 8-OHdG. This initiates demethylation of 5mC[25] as shown in the previous figure.

For a TET enzyme to initiate demethylation it must first be recruited to a methylated CpG site in DNA. Two of the proteins shown to recruit a TET enzyme to a methylated cytosine in DNA are OGG1 (see figure Initiation of DNA demethylation at a CpG site)[25] and EGR1.[26]

OGG1

[edit]

Oxoguanine glycosylase (OGG1) catalyses the first step in base excision repair of the oxidatively damaged base 8-OHdG. OGG1 finds 8-OHdG by sliding along the linear DNA at 1,000 base pairs of DNA in 0.1 seconds.[27] OGG1 very rapidly finds 8-OHdG. OGG1 proteins bind to oxidatively damaged DNA with a half maximum time of about 6 seconds.[28] When OGG1 finds 8-OHdG it changes conformation and complexes with 8-OHdG in its binding pocket.[29] OGG1 does not immediately act to remove the 8-OHdG. Half maximum removal of 8-OHdG takes about 30 minutes in HeLa cells in vitro,[30] or about 11 minutes in the livers of irradiated mice.[31] DNA oxidation by reactive oxygen species preferentially occurs at a guanine in a methylated CpG site, because of a lowered ionization potential of guanine bases adjacent to 5-methylcytosine.[32] TET1 binds (is recruited to) the OGG1 bound to 8-OHdG (see figure).[25] This likely allows TET1 to demethylate an adjacent methylated cytosine. When human mammary epithelial cells (MCF-10A) were treated with H2O2, 8-OHdG increased in DNA by 3.5-fold and this caused about 80% demethylation of the 5-methylcytosines in the MCF-10A genome.[25]

EGR1

[edit]

The gene early growth response protein 1 (EGR1) is an immediate early gene (IEG). EGR1 can rapidly be induced by neuronal activity.[33] The defining characteristic of IEGs is the rapid and transient up-regulation—within minutes—of their mRNA levels independent of protein synthesis.[34] In adulthood, EGR1 is expressed widely throughout the brain, maintaining baseline expression levels in several key areas of the brain including the medial prefrontal cortex, striatum, hippocampus and amygdala.[34] This expression is linked to control of cognition, emotional response, social behavior and sensitivity to reward.[34] EGR1 binds to DNA at sites with the motifs 5′-GCGTGGGCG-3′ and 5'-GCGGGGGCGG-3′ and these motifs occur primarily in promoter regions of genes.[33] The short isoform TET1s is expressed in the brain. EGR1 and TET1s form a complex mediated by the C-terminal regions of both proteins, independently of association with DNA.[33] EGR1 recruits TET1s to genomic regions flanking EGR1 binding sites.[33] In the presence of EGR1, TET1s is capable of locus-specific demethylation and activation of the expression of downstream genes regulated by EGR1.[33]

DNA demethylation intermediate 5hmC

[edit]

As indicated in the Figure above, captioned "Demethylation of 5-methylcytosine," the first step in active demethylation is a TET oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). The demethylation process, in some tissues and at some genome locations, may stop at that point. As reviewed by Uribe-Lewis et al.,[35] in addition to being an intermediate in active DNA demethylation, 5hmC is often a stable DNA modification. Within the genome, 5hmC is located at transcriptionally active genes, regulatory elements and chromatin associated complexes. In particular, 5hmC is dynamically changed and positively correlated with active gene transcription during cell lineage specification, and high levels of 5hmC are found in embryonic stem cells and in the central nervous system.[36] In humans, defective 5-hydroxymethylating activity is associated with a phenotype of lymphoproliferation, immunodeficiency and autoimmunity.[37]

Stage 3 base excision repair

[edit]
An example of base excision repair of 5-formylcytosine (5fC) (adjacent to 8-OHdG, an oxidized guanine) by short patch repair or long patch repair. Two strands of DNA are represented by parallel horizontal lines. The first downward arrow shows thymine DNA glycosylase (TDG) removing 5-formylcytosine (5fC) from the DNA backbone, leaving an apyrimidinic site. Then AP endonuclease cleaves the 5′ deoxyribose-phosphate in the DNA backbone of a single strand, leaving a 3′ hydroxy end and a 5′ deoxyribose phosphate end (second downward arrow). This is followed by either short patch or long patch repair. In short patch repair, 5′ dRP lyase trims the 5′ dRP end to form a phosphorylated 5′ end. This is followed by DNA polymerase β (Pol β) adding a single cytosine opposite the pre-existing guanine in the complementary strand and then DNA ligase to seal the cut strand. In long patch repair, DNA synthesis is thought to be mediated by polymerase δ and polymerase ε performing displacing synthesis to form a flap. Pol β can also perform long-patch displacing synthesis. Long-patch synthesis typically inserts 2–10 new nucleotides. Then flap endonuclease removes the flap, and this is followed by DNA ligase to seal the strand.

The third stage of DNA demethylation is removal of the intermediate products of demethylation generated by a TET enzyme by base excision repair. As indicated above in Stage 2, after 5mC is first oxidized by a TET to form 5hmC, further oxidation of 5hmC by TET yields 5fC and oxidation of 5fC by TET yields 5caC. Both 5fC and 5caC are recognized by a DNA glycosylase, TDG, a base excision repair enzyme, as an abnormal base. As shown in the Figure in this section, TDG removes the abnormal base (e.g. 5fC) while leaving the sugar-phosphate backbone intact, creating an apurinic/apyrimidinic site, commonly referred to as an AP site. In this Figure, the 8-OHdG is left in the DNA, since it may have been present when OGG1 attracted TET1 to the CpG site with a methylated cytosine. After an AP site is formed, AP endonuclease creates a nick in the phosphodiester backbone of the AP site that was formed when the TDG DNA glycosylase removed the 5fC or 5caC. The human AP endonuclease incises DNA 5′ to the AP site by a hydrolytic mechanism, leaving a 3′-hydroxyl and a 5′-deoxyribose phosphate (5' dRP) residue.[38] This is followed by either short patch or long patch repair. In short patch repair, 5′ dRP lyase trims the 5′ dRP end to form a phosphorylated 5′ end. This is followed by DNA polymerase β (pol β) adding a single cytosine to pair with the pre-existing guanine in the complementary strand and then DNA ligase to seal the cut strand. In long patch repair, DNA synthesis is thought to be mediated by polymerase δ and polymerase ε performing displacement synthesis to form a flap. Pol β can also perform long-patch displacement synthesis. Long-patch synthesis typically inserts 2–10 new nucleotides. Then flap endonuclease removes the flap, and this is followed by DNA ligase to seal the strand. At this point there has been a complete replacement of the 5-methylcytosine by cytosine (demethylation) in the DNA sequence.

Demethylation after exercise

[edit]

Physical exercise has well established beneficial effects on learning and memory (see Neurobiological effects of physical exercise). BDNF is a particularly important regulator of learning and memory.[39] As reviewed by Fernandes et al.,[40] in rats, exercise enhances the hippocampus expression of the gene Bdnf, which has an essential role in memory formation. Enhanced expression of Bdnf occurs through demethylation of its CpG island promoter at exon IV[40] and this demethylation depends on steps illustrated in the two figures.[19]

[edit]

In a panel of healthy adults, negative associations were found between total DNA methylation and exposure to traffic related air pollution. DNA methylation levels were associated both with recent and chronic exposure to Black Carbon as well as benzene.[41]

Peripheral sensory neuron regeneration

[edit]

After injury, neurons in the adult peripheral nervous system can switch from a dormant state with little axonal growth to robust axon regeneration. DNA demethylation in mature mammalian neurons removes barriers to axonal regeneration.[42] This demethylation, in regenerating mouse peripheral neurons, depends upon TET3 to generate 5-hydroxymethylcytosine (5hmC) in DNA.[42][43] 5hmC was altered in a large set of regeneration-associated genes (RAGs), including well-known RAGs such as Atf3, Bdnf, and Smad1, that regulate the axon growth potential of neurons.[43]

See also

[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
DNA demethylation is an epigenetic process that removes methyl groups from 5-methylcytosine (5mC) bases in DNA, thereby reversing DNA methylation and modulating gene expression without altering the underlying genetic sequence.[1] This process occurs through two primary mechanisms: passive demethylation, which involves the dilution of 5mC during DNA replication due to inhibition or absence of maintenance methyltransferases like DNMT1, and active demethylation, which enzymatically modifies 5mC independently of replication.[2] In active demethylation, ten-eleven translocation (TET) enzymes (TET1, TET2, and TET3) oxidize 5mC to 5-hydroxymethylcytosine (5hmC), and further to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), with the latter two intermediates excised by thymine DNA glycosylase (TDG) and replaced with unmodified cytosine via base excision repair (BER).[1] These mechanisms ensure dynamic control of the epigenome, expanding the repertoire of cytosine modifications beyond 5mC to include 5hmC, 5fC, and 5caC as transient or stable marks.[1] TET-mediated active demethylation plays pivotal roles in mammalian development, particularly in epigenetic reprogramming events such as the rapid demethylation of the paternal genome in zygotes by TET3 and global erasure in primordial germ cells (PGCs) to establish totipotency and prevent epigenetic inheritance of parental marks.[1] In pluripotent stem cells and during neuronal differentiation, elevated 5hmC levels—reaching up to 40% of 5mC in brain tissue—facilitate enhancer activation, alternative splicing, and neuroplasticity by antagonizing methyl-binding proteins and promoting open chromatin.[1] Dysregulation of these processes is implicated in diseases; for instance, TET2 mutations reduce demethylation efficiency in acute myeloid leukemia, leading to aberrant hypermethylation and oncogenic gene silencing, while vitamin C enhances TET activity to support demethylation in cancer therapy contexts.[1] The regulation of DNA demethylation integrates multiple layers, including TET enzyme localization to CpG-rich promoters and enhancers via interactions with transcription factors, cofactor availability (e.g., α-ketoglutarate and Fe²⁺), and post-translational modifications like O-GlcNAcylation that modulate TET stability and activity.[1] Passive mechanisms complement active ones during cell division in contexts like induced pluripotency, where incomplete maintenance methylation allows progressive demethylation of lineage-specific genes.[2] Overall, these processes maintain epigenetic plasticity, with 5hmC serving as both an intermediate in demethylation and a distinct epigenetic signal that influences genomic stability and cellular identity.[1]

Fundamentals

Definition and Biological Importance

DNA demethylation refers to the enzymatic or replication-dependent removal of methyl groups from 5-methylcytosine (5mC) residues, which are primarily found at CpG dinucleotides in eukaryotic DNA. This process reverses the covalent addition of a methyl group to the 5-position of cytosine, a modification that typically establishes stable gene repression by interfering with transcription factor binding or recruiting repressive chromatin complexes. In contrast to the persistence of DNA methylation, demethylation introduces reversibility to this epigenetic mark, allowing for tunable control over genomic accessibility.[3][4] The biological importance of DNA demethylation lies in its capacity to facilitate dynamic alterations in gene expression without changing the DNA sequence, thereby underpinning epigenetic plasticity in diverse cellular contexts. It is essential for cellular differentiation, where demethylation activates lineage-specific genes during development; for adaptive responses to external stimuli, such as nutrient availability or immune challenges; and for preserving epigenetic homeostasis, ensuring proper inheritance and maintenance of methylation patterns across generations of cells. Disruptions in demethylation can lead to aberrant gene silencing or activation, contributing to developmental disorders and diseases like cancer.[5][6][7] DNA demethylation was first described in the early 1980s through observations of methylation changes associated with gene activation in mammalian development, highlighting its role in epigenetic reprogramming. Key breakthroughs in the 2010s identified the TET family of enzymes as central players in active demethylation pathways, providing mechanistic insights that expanded beyond earlier replication-dependent models. Demethylation patterns vary between global erasure, which occurs extensively in zygotes and primordial germ cells to reset epigenetic marks, and locus-specific targeting, which precisely modulates individual gene loci for fine-tuned transcriptional control.00071-3)[8][9]

Active Versus Passive Demethylation

DNA demethylation occurs through two primary mechanisms: passive and active processes, which differ fundamentally in their dependency on DNA replication, speed, and biological contexts. Passive demethylation is a replication-dependent process characterized by the dilution of 5-methylcytosine (5mC) marks over successive cell divisions due to the failure of maintenance methylation by DNA methyltransferase 1 (DNMT1).[10] During DNA synthesis, the parental strand's methylation is not faithfully copied to the daughter strand if DNMT1 activity is inhibited or absent, leading to a progressive, global loss of methylation that requires multiple rounds of replication to achieve significant erasure. This mechanism is inherently slower and operates on a broad scale, often affecting large genomic regions without targeted specificity.[3] In contrast, active demethylation is a replication-independent enzymatic process that enables the rapid and targeted removal of 5mC marks, even in non-dividing cells. It involves direct modification of the methylated cytosine base, typically through oxidation by ten-eleven translocation (TET) enzymes, followed by repair pathways that excise and replace the modified base with unmodified cytosine.[10] This allows for swift changes in DNA methylation status, often at specific loci, and is crucial for dynamic regulation in post-mitotic tissues.[11] Unlike passive demethylation, active processes can occur independently of the cell cycle, providing a mechanism for immediate responses to environmental or developmental cues.[3] The distinctions between these modes are evident in their timing and applications during development and cellular function. Passive demethylation predominates in the maternal genome during early embryonic preimplantation stages, where it facilitates global reprogramming through replication-coupled dilution over several cell divisions.[12] Conversely, active demethylation is prominent in the paternal pronucleus shortly after fertilization, enabling rapid erasure within hours, as well as in mature neurons for activity-dependent gene expression, such as at the BDNF promoter.[12] These complementary pathways ensure versatile control over the epigenome, with passive mechanisms suiting gradual, widespread changes and active ones supporting precise, urgent modifications.[13]

Molecular Mechanisms

Passive Demethylation Process

Passive DNA demethylation occurs through a replication-dependent process that dilutes 5-methylcytosine (5mC) levels across successive cell divisions when maintenance methylation is impaired. During S-phase of the cell cycle, DNA replication produces hemimethylated daughter strands where only the parental strand retains the 5mC mark at CpG sites. Normally, the maintenance methyltransferase DNMT1, guided by its cofactor UHRF1, recognizes these hemimethylated sites via UHRF1's binding to hemimethylated DNA and restores symmetric methylation on the new strand. However, if UHRF1 binding is disrupted—due to low protein levels, altered localization, or interference—or if DNMT1 activity is reduced, the new strand remains unmethylated, leading to a progressive halving of 5mC density with each replication cycle.[14][15] Several factors can impair this maintenance process, including downregulation of DNMT1 expression or activity through cell cycle regulation, such as in phases with limited DNMT1 nuclear localization. Pharmacological inhibitors like decitabine, a cytidine analog, further promote passive demethylation by incorporating into DNA and covalently trapping DNMT1, which triggers its degradation and depletes functional enzyme levels over multiple divisions. This results in incomplete remethylation and cumulative 5mC loss, distinct from the faster, replication-independent nature of active demethylation.[16][17] The outcome of passive demethylation is a gradual, genome-wide reduction in 5mC, often quantified by bisulfite sequencing, which converts unmethylated cytosines to uracils while preserving 5mC, allowing detection of dilution as methylation ratios decrease across cell generations. In experimental models, such as UHRF1-deficient embryonic stem cells, bisulfite sequencing reveals near-complete loss of 5mC after several passages, confirming the replication-coupled dilution.[18][19][14] This mechanism is particularly prominent in contexts requiring rapid epigenetic reprogramming, such as pre-implantation embryos, where high proliferation rates amplify the dilution effect due to transient suppression of UHRF1 and DNMT1 activity following fertilization. In mouse zygotes, passive demethylation primarily accounts for global 5mC erasure on the maternal genome, while the paternal genome undergoes active demethylation. In blastocysts, further passive dilution contributes to erasure on both genomes, erasing gametic imprints to enable totipotency.[20][21][22]

TET-Mediated Oxidation in Active Demethylation

Active DNA demethylation is initiated by the ten-eleven translocation (TET) family of enzymes, which catalyze the oxidation of 5-methylcytosine (5mC) in DNA. The TET proteins—TET1, TET2, and TET3—are Fe(II)- and α-ketoglutarate (α-KG)-dependent dioxygenases that iteratively oxidize 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC). This stepwise oxidation process provides a mechanism for replication-independent removal of methylation marks, contrasting with passive dilution during cell division. The reactions require molecular oxygen and produce succinate and carbon dioxide as byproducts, with each step involving the insertion of the modified cytosine into the enzyme's catalytic pocket via a base-flipping mechanism. TET1 and TET2 typically perform sequential oxidations, converting 5mC to 5hmC, then further to 5fC and 5caC, allowing for fine-tuned regulation of demethylation at specific genomic loci. In contrast, TET3 excels at the initial rapid conversion of 5mC to 5hmC, particularly in the paternal pronucleus of zygotes, where it facilitates widespread demethylation shortly after fertilization. This TET3-driven oxidation is essential for early embryonic genome reprogramming, generating high levels of 5hmC that serve as intermediates for subsequent processing. Structural insights from the 2013 crystal structure of TET2 bound to DNA reveal how the enzyme's CXXC domain recognizes unmethylated CpG sites while the catalytic domain flips and oxidizes 5mC, confirming the specificity of these interactions. Expression of TET enzymes is tightly regulated by transcription factors, such as FOXA1 for TET1 in certain cellular contexts, enabling context-specific activation during development and differentiation. Additionally, cofactors like ascorbate (vitamin C) enhance TET activity by maintaining the Fe(II) state and promoting substrate binding, thereby boosting oxidation efficiency and demethylation rates. Knockout studies underscore the functional importance of TET proteins; for instance, combined Tet1/Tet2 deficiency in mouse embryonic stem cells impairs 5hmC production and leads to defective differentiation due to persistent hypermethylation at key regulatory regions. Similarly, Tet3 ablation disrupts zygotic demethylation, resulting in developmental delays and highlighting the non-redundant roles of these enzymes in active demethylation pathways.

Base Excision Repair Completion

In active DNA demethylation, the base excision repair (BER) pathway processes the TET-generated intermediates 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) to replace them with unmodified cytosine. Thymine DNA glycosylase (TDG) specifically recognizes and excises 5fC or 5caC when base-paired with guanine in CpG contexts, generating an abasic (AP) site in the DNA strand.[23][24] AP endonuclease 1 (APE1) then hydrolyzes the phosphodiester backbone 5' to the AP site, creating a single-strand break with a 3'-hydroxyl end and a 5'-deoxyribose phosphate (dRP) blocking group.[25] DNA polymerase β (POLβ) removes the 5'-dRP via its lyase activity and inserts an unmodified cytosine opposite the guanine, while DNA ligase 3 (LIG3), often in complex with XRCC1, seals the nick to restore the DNA duplex.[25][26] This process primarily follows the short-patch BER subpathway, which replaces a single nucleotide and predominates for monofunctional glycosylases like TDG due to the clean 3'-OH end generated by APE1.[27] In contrast, long-patch BER, involving DNA polymerase δ/ε and flap endonuclease 1 (FEN1) to synthesize 2–10 nucleotides, may occur if the 5'-dRP blocks POLβ, though it is less common in demethylation contexts.[28] An alternative glycosylase, single-strand-selective monofunctional uracil-DNA glycosylase (SMUG1), can process 5-hydroxymethylcytosine (5hmC) indirectly by excising its deamination product 5-hydroxymethyluracil (5hmU), providing a backup route for BER initiation in demethylation.[29][30] Efficiency of BER completion is modulated by poly(ADP-ribose) polymerase 1 (PARP1), which detects the single-strand break and covalently PARylates BER factors like XRCC1, APE1, POLβ, and LIG3 to enhance their recruitment and activity at the site.[31] Unrepaired AP sites or strand breaks from incomplete BER can block advancing replication forks, leading to fork stalling, ssDNA gap formation, and potential genomic instability if not resolved by factors like PRIMPOL or the Fanconi anemia pathway.[32][33] Experimental validation includes in vitro reconstitution assays using purified TET1, TDG, APE1, POLβ, and LIG3, which demonstrate sequential oxidation, excision, and replacement of 5-methylcytosine to yield unmodified cytosine without replication.[25] TDG knockout mice exhibit embryonic lethality around E10.5, with widespread hypermethylation at CpG islands and failure to demethylate key developmental enhancers, underscoring TDG's essential role in BER-mediated demethylation.[34]

Key Intermediates and Regulators

5-Hydroxymethylcytosine and Oxidized Derivatives

5-Hydroxymethylcytosine (5hmC) serves as a key stable epigenetic modification generated through the oxidation of 5-methylcytosine (5mC) by ten-eleven translocation (TET) enzymes in the active DNA demethylation pathway. Unlike the transient nature of further oxidation products, 5hmC persists as a relatively stable mark, with levels enriched in neuronal tissues and pluripotent stem cells, where it constitutes up to 40% of modified cytosines in regions such as gene bodies and enhancers. In the brain, 5hmC abundance increases developmentally, reaching approximately 0.6-0.7% of total cytosines in adult human cerebral cortex, reflecting its role in maintaining epigenetic landscapes beyond mere demethylation intermediates. Detection of 5hmC relies on methods that exploit its chemical properties, such as glucosylation using β-glucosyltransferase to protect it from further enzymatic modification, enabling enrichment techniques like glucosylation-induced immunoprecipitation (GLIB) for locus-specific mapping.[35] For base-resolution analysis, TET-assisted bisulfite sequencing (TAB-seq) involves glucosylation of 5hmC followed by TET-mediated oxidation of unprotected 5mC to 5-carboxylcytosine (5caC), with subsequent bisulfite conversion distinguishing 5hmC as resistant cytosine during sequencing.[36] These approaches provide single-nucleotide precision and quantitative insights into 5hmC distribution, overcoming limitations of bisulfite sequencing that conflates 5hmC with 5mC.[36] Further oxidation by TET enzymes produces 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), which act as transient and highly unstable intermediates in active demethylation, rapidly processed due to their chemical reactivity and low steady-state levels—typically 10- to 100-fold lower than 5hmC. 5caC, in particular, exhibits the lowest abundance among these derivatives, serving primarily as a substrate for thymine-DNA glycosylase (TDG) to initiate base excision repair and complete cytosine restoration. Their instability contributes to replication-dependent dilution in dividing cells, ensuring efficient progression through the demethylation cascade without prolonged accumulation.[37] Beyond demethylation, 5hmC functions as an instructive mark by recruiting reader proteins such as methyl-CpG-binding protein 2 (MeCP2), which interacts with 5hmC-modified regions to modulate chromatin structure and gene expression. This recruitment influences alternative splicing, where 5hmC in gene bodies correlates with exon inclusion patterns by altering the binding of splicing factors and promoting transcriptional elongation efficiency.[38] Quantification of 5hmC and its derivatives employs mass spectrometry techniques, such as liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS), which hydrolyzes DNA into nucleosides for sensitive detection down to 0.1% relative abundance using multiple reaction monitoring.[39] Antibody-based methods, including hydroxymethylated DNA immunoprecipitation (hMeDIP), further enable tissue-specific profiling by affinity enrichment of 5hmC fragments for downstream analysis. Notably, 5hmC levels vary markedly across tissues, with exceptionally high concentrations in cerebellar Purkinje neurons—approaching 40% of total 5mC/5hmC—compared to lower levels in non-neuronal tissues like lung (0.14%) or heart (0.05-0.06%).

Recruitment Factors and Enzymes

The recruitment of ten-eleven translocation (TET) enzymes to specific genomic loci is mediated primarily by their CXXC zinc-finger domains, which preferentially bind to unmethylated CpG dinucleotides, thereby targeting TET1 and TET3 to CpG-rich regions containing unmethylated CpGs, such as promoters and CpG islands.[40] For TET2, which lacks an intrinsic CXXC domain, recruitment is facilitated by the CXXC domain-containing protein IDAX, which binds unmethylated CpG sites and interacts directly with TET2 to guide it to target loci.[41] This mechanism ensures locus-specific oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and further derivatives, as observed in embryonic stem cells where CXXC-mediated binding correlates with active demethylation sites.[40] Transcription factors further enhance TET recruitment for guided targeting. The early growth response 1 (EGR1) transcription factor physically interacts with TET1, recruiting it to promoter regions of neuronal genes during development to facilitate demethylation and gene activation.[42] Similarly, the DNA glycosylase OGG1 binds to oxidized guanines within methylated CpG sites and recruits TET1 to initiate demethylation, particularly in contexts involving oxidative stress and memory formation.[43] These interactions allow TET enzymes to respond to environmental and developmental cues, achieving precise epigenetic reprogramming. Post-translational modifications also regulate TET activity and stability. The histone acetyltransferases CBP and p300 acetylate TET2 at specific lysine residues, enhancing its enzymatic activity and stability to promote efficient demethylation at hematopoietic gene loci.[44] Under hypoxic conditions, hypoxia-inducible factor 1α (HIF1α) stabilizes TET1 by preventing its proteasomal degradation, thereby upregulating TET1-mediated demethylation in adipocyte differentiation and tumor microenvironments.[45] Accessory enzymes form complexes with TET to complete targeted demethylation. Thymine DNA glycosylase (TDG) partners with TET enzymes in a sequential manner, where TET oxidation generates substrates (5-formylcytosine and 5-carboxylcytosine) that TDG excises to enable base excision repair, as demonstrated in biochemical reconstitution assays showing coupled TET-TDG action at non-CpG sites.[25] Apurinic/apyrimidinic endonuclease 1 (APE1) integrates into this repair complex, processing abasic sites generated by TDG and preventing mismatch extension during demethylation, thereby maintaining CpG integrity in proliferating cells.[46] Locus specificity of TET recruitment is evident in developmental contexts, where chromatin immunoprecipitation followed by sequencing (ChIP-seq) data reveal TET2 enrichment at poised enhancers in embryonic stem cells, facilitating transcription factor binding and lineage-specific gene activation.[47] For instance, in mouse embryonic stem cells, TET1 ChIP-seq profiles show preferential occupancy at bivalent enhancers marked by H3K4me1, correlating with dynamic demethylation during differentiation.[48] These patterns underscore TET's role in enhancer priming for developmental gene regulation.

Roles in Development and Reproduction

Early Embryonic Reprogramming

Following fertilization in mammals, the zygote undergoes a profound epigenetic reprogramming event characterized by global DNA demethylation of the paternal genome through an active process mediated by TET3, which oxidizes 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and further derivatives, facilitating rapid loss of methylation marks shortly after sperm entry.[49] In contrast, the maternal genome experiences passive demethylation, primarily due to dilution of 5mC during successive cell divisions in the absence of efficient maintenance by DNMT1/UHRF1 complexes.00341-5) This asymmetric reprogramming establishes distinct epigenetic landscapes for the parental pronuclei within the same zygotic cytoplasm, with paternal demethylation initiating as early as 6 hours post-fertilization in mice.[49] As development progresses to the preimplantation stages, a second wave of demethylation occurs in the inner cell mass (ICM) of the blastocyst, resulting in substantial erasure of 5mC levels to approximately 10% genome-wide in mice.[50][20] This extensive erasure resets the epigenetic state, protecting against the transgenerational inheritance of potentially deleterious epimutations from gametes and enabling totipotency in embryonic lineages.[51] Single-cell sequencing technologies developed in the 2010s have provided high-resolution evidence of these dynamics, revealing heterogeneous methylation patterns across individual cells from the zygote to the blastocyst stage and confirming the progressive nature of this reprogramming in mammals. Notably, certain genomic regions escape this demethylation to preserve essential functions. Imprinted loci, which regulate parent-of-origin-specific gene expression, are protected from active and passive erasure by the maternal factor Stella (also known as PGC7), which binds to these sites and shields them from TET3-mediated oxidation and replication-dependent dilution.[52] This selective protection ensures the stability of imprinting marks through early embryogenesis, preventing disruptions to developmental programs.

Gametogenesis and Germline Demethylation

During gametogenesis, DNA demethylation plays a critical role in erasing epigenetic marks from the parental genome within primordial germ cells (PGCs) and prospermatogonia, enabling the establishment of totipotency in the next generation while selectively preserving genomic imprints and silencing retrotransposons. This reprogramming occurs primarily in the germline to reset the epigenome, distinct from post-fertilization events. In both oogenesis and spermatogenesis, demethylation involves a combination of active oxidation by TET enzymes and passive dilution through replication without maintenance by DNMT1, ensuring broad erasure except at protected loci.00019-2) In oogenesis, demethylation transitions from the global erasure in PGCs to selective maintenance during oocyte growth, where passive demethylation predominates due to limited DNMT1 activity during follicular development, complemented by localized active processes at non-imprinted regions. DNMT3L, acting as a cofactor for DNMT3A, mediates the protection and establishment of maternal imprints by directing de novo methylation to imprinting control regions (ICRs), preventing their erasure and ensuring parent-of-origin-specific gene expression in the embryo. This selective retention is vital, as DNMT3L deficiency leads to hypomethylation of imprints and oocyte incompetence. Growing oocytes thus achieve a patterned methylome, with approximately 40% global CpG methylation by the germinal vesicle stage, balancing erasure with imprint fidelity.[53][54][55] In spermatogenesis, more pronounced active demethylation occurs in prospermatogonia, driven by TET1 and TET2, which oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and further derivatives, facilitating base excision repair and global hypomethylation to levels as low as 10-20% before de novo remethylation in spermatogonia. This TET-mediated process is essential for germline reprogramming, with Tet1/2 double knockouts causing severe methylation retention and meiotic defects. Concurrently, piRNA-guided mechanisms retain silencing of retrotransposons, such as LINE-1 elements, by directing DNMT3A/3L to methylate their loci post-demethylation, preventing transposon activation and genomic instability during meiosis. piRNA clusters produce antisense transcripts that target transposons for methylation, ensuring ~90% of young retrotransposons remain silenced in mature sperm.00019-2)[56][57] The outcomes of this demethylation establish totipotency by creating a naive epigenetic state in gametes, allowing zygotic genome activation and flexible developmental potential, while imprint protection maintains essential monoallelic expression. Errors in this process, such as incomplete demethylation or imprint loss, are linked to infertility, including azoospermia in males and oocyte aneuploidy in females, often manifesting as reduced fertility rates and embryonic lethality. Species differences highlight more robust active demethylation in mice via TET1/2 in prospermatogonia, achieving faster erasure compared to humans, where passive mechanisms dominate in early PGCs, resulting in slower kinetics and higher residual methylation (~30-50% at certain stages). These variations underscore the need for species-specific models in reproductive epigenetics research.[58][59][60]

Physiological Functions

Learning, Memory, and Neural Plasticity

DNA demethylation plays a crucial role in synaptic plasticity and memory formation through locus-specific active processes mediated by TET enzymes in neurons. Neuronal activity triggers the activation of TET1 and TET3, which oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) at promoters of key activity-regulated genes, facilitating their expression. For instance, brain-derived neurotrophic factor (BDNF) signaling pathways induce TET1 expression, leading to demethylation at the Bdnf promoter exon IX, thereby enhancing BDNF transcription essential for synaptic strengthening. Similarly, TET1 and TET3 contribute to demethylation at the Arc promoter, an immediate early gene involved in synaptic remodeling and long-term potentiation (LTP).[61][62] Evidence from mouse models demonstrates these mechanisms in learning paradigms, particularly contextual fear conditioning, where increased 5hmC levels occur in the hippocampus following training. In wild-type mice, fear conditioning induces TET1-dependent accumulation of 5hmC at promoters of memory-related genes like Bdnf and Fgf1b, correlating with enhanced gene expression and memory consolidation. Studies since 2013 have shown that TET1 knockout mice exhibit altered 5hmC dynamics and fail to properly demethylate these loci, resulting in disrupted activity-induced transcription despite normal baseline methylation levels.[61] These processes support long-term neural adaptations, with TET-mediated demethylation facilitating LTP induction and maintenance in hippocampal circuits. TET1-deficient mice display normal LTP but enhanced long-term depression (LTD) at Schaffer collateral-CA1 synapses and deficits in memory extinction after fear conditioning, underscoring the enzyme's role in balancing methylation for adaptive plasticity. Conditional TET3 knockout similarly impairs spatial memory in tasks like the Morris water maze, highlighting its contribution to hippocampal-dependent learning.[61][63] In humans, dysregulation of TET enzymes, particularly TET2, is implicated in neurodegenerative disorders affecting cognition, such as Alzheimer's disease (AD). Reduced TET2 expression exacerbates amyloid-beta-induced neuronal damage and tau hyperphosphorylation in AD models, leading to impaired demethylation and synaptic dysfunction. Abnormal TET2 levels in the hippocampus correlate with cognitive decline in AD patients, suggesting that TET2 dysregulation disrupts the epigenetic regulation of plasticity genes, contributing to memory loss.[64][65]

Exercise-Induced and Sensory Regeneration

Physical exercise triggers acute DNA demethylation at promoters of key metabolic genes in skeletal muscle, notably PGC-1α, which encodes a transcriptional coactivator essential for mitochondrial biogenesis and energy metabolism. This hypomethylation occurs rapidly following bouts of aerobic exercise in humans, correlating with increased gene expression and adaptive metabolic responses. Studies from the early 2010s demonstrated that a single session of cycling exercise reduced methylation levels at the PGC-1α promoter in vastus lateralis muscle biopsies, facilitating enhanced transcription within hours.[66] Similarly, post-exercise elevations in 5-hydroxymethylcytosine (5hmC), an intermediate in TET-mediated active demethylation, have been observed in human skeletal muscle, indicating dynamic epigenetic remodeling in response to contractile activity. For instance, muscle contraction induces site-specific 5hmC accumulation at exercise-responsive loci, supporting transcriptional activation.[66] In the context of sensory regeneration, TET-mediated demethylation plays a critical role in promoting axon regrowth in peripheral neurons following injury, particularly in dorsal root ganglion (DRG) models. Peripheral nerve injury upregulates TET3 expression in DRG neurons, leading to increased 5hmC levels and demethylation of regeneration-associated genes, which enhances axonal outgrowth and functional recovery. Genetic ablation of Tet3 impairs this process, resulting in reduced axon regeneration and poorer behavioral outcomes in injury models, underscoring TET3's necessity for epigenetic reprogramming in sensory neurons. Although TET1 has been implicated in central nervous system regeneration contexts, TET3 predominates in peripheral sensory repair.[67] These processes are mechanistically linked to activity-induced reactive oxygen species (ROS) and downstream signaling that recruit TET enzymes to target loci. Exercise or injury-generated ROS can modulate TET activity by altering cofactor availability or directly influencing enzyme expression, thereby promoting oxidation of 5-methylcytosine and subsequent demethylation. In muscle, ROS from contraction inhibits DNA methyltransferases while potentially upregulating TETs, facilitating hypomethylation at metabolic enhancers; analogous signaling in neurons post-injury drives TET3 recruitment to pro-regenerative genes.[68] The functional outcomes of these epigenetic changes include improved endurance capacity through PGC-1α-driven mitochondrial adaptations in muscle, as demethylation supports sustained aerobic performance in response to repeated exercise. In sensory contexts, TET-mediated demethylation holds therapeutic promise for peripheral neuropathies, where enhancing TET activity could accelerate nerve repair and alleviate symptoms in conditions like diabetic neuropathy or traumatic injury.[66][67]

Disease and Environmental Associations

Demethylation Dysregulation in Cancer

DNA demethylation dysregulation in cancer primarily manifests as global hypomethylation and alterations in TET enzymes, contributing to oncogenesis through genomic instability and aberrant gene expression. Global hypomethylation, observed in most cancer types, leads to chromosomal instability by reactivating transposable elements and promoting tumor heterogeneity. This process also activates oncogenes, such as those involved in cell proliferation, by reducing methylation at promoter regions. Additionally, hypomethylation of satellite repeats, including satellite 2 DNA (Sat2), is a frequent epigenetic alteration in cancers like colorectal and ovarian tumors, resulting in overexpression of non-coding satellite RNAs that disrupt chromatin structure and enhance tumorigenicity.00031-2)[69][70][71][72] Alterations in TET enzymes, particularly TET2, are prominent in hematologic malignancies and drive leukemogenesis by impairing oxidative demethylation. TET2 mutations occur in approximately 20-28% of acute myeloid leukemia (AML) cases, often as loss-of-function variants that reduce 5-hydroxymethylcytosine (5hmC) levels at gene enhancers and promoters. This 5hmC depletion leads to hypermethylation at specific loci, aberrant self-renewal of hematopoietic stem cells, and blocked differentiation, thereby promoting clonal expansion and disease progression. The TET family, including TET1, TET2, and TET3, catalyzes the conversion of 5-methylcytosine (5mC) to 5hmC as the initial step in active demethylation.[73][74]30868-1) The Cancer Genome Atlas (TCGA) datasets across multiple tumor types, including breast, lung, and glioma, reveal consistent global loss of 5hmC, correlating with advanced disease stages and poor prognosis. This 5hmC reduction is independent of TET mutations in some solid tumors but underscores the broad disruption of demethylation pathways in oncogenesis. Therapeutically, enhancing TET activity offers promise; high-dose vitamin C acts as a cofactor to boost TET-mediated 5hmC production, with ongoing clinical trials in AML and other cancers demonstrating improved outcomes by reversing hypermethylation and sensitizing cells to chemotherapy. Efforts to develop TET activators and inhibitors of thymine DNA glycosylase (TDG), which completes the demethylation pathway, are also advancing to restore epigenetic balance in TET-deficient tumors.[75][76][77][78][79]

Impacts of Pollution and Other Exposures

Exposure to fine particulate matter (PM2.5) from traffic pollution has been shown to induce locus-specific DNA demethylation, particularly at genes involved in inflammation, as observed in cohort studies from the 2010s. For instance, short-term PM2.5 exposure is associated with reduced DNA methylation at specific loci regulating gene expression related to inflammatory responses, potentially exacerbating respiratory conditions.[80] In a large-scale epigenome-wide association study (EWAS) of Han Chinese adults, long-term PM2.5 exposure correlated with altered methylation patterns at CpG sites near inflammation-associated genes, linking these changes to increased risk of respiratory diseases such as asthma.[81] Developmental exposure to PM2.5 in animal models further demonstrates genome-wide hypomethylation in response to allergens, priming heightened airway hyperreactivity in adulthood.[82] Tobacco smoke exposure leads to pronounced hypomethylation of the aryl hydrocarbon receptor repressor (AHRR) gene, specifically at the cg05575921 CpG site, serving as a robust biomarker of smoking intensity and duration.[83] This demethylation persists in former smokers and is associated with cumulative tobacco exposure, influencing pathways related to detoxification and inflammation.[84] Prenatal tobacco smoke exposure similarly causes AHRR hypomethylation in offspring, mediating metabolic dysfunction and underscoring the intergenerational impact of this exposure.[85] Heavy metal exposures, such as arsenic, inhibit ten-eleven translocation (TET) enzymes through oxidative stress, leading to hypermethylation at promoters of genes like OGG1 and GSTP1 involved in antioxidant defense.[86][87] This TET-mediated inhibition impairs cellular responses to oxidative damage and dysregulates epigenomic stability in exposed tissues. The primary mechanism linking these exposures to DNA demethylation involves reactive oxygen species (ROS)-mediated recruitment and activation of TET proteins, which oxidize 5-methylcytosine to facilitate active demethylation.[68] ROS generated by pollutants modulate TET expression and activity, altering the epigenetic landscape in a locus-specific manner.[88] These changes can exhibit transgenerational effects, where low-dose pollutant exposure induces stable epigenetic alterations, including hypomethylation patterns, transmitted across multiple generations in model organisms.[89] Such pollution-induced demethylation contributes to elevated health risks, including asthma exacerbation through inflammatory gene activation and increased susceptibility to cancers via epigenetic dysregulation overlapping with oncogenic pathways.[82] Mitigation strategies, such as dietary antioxidants, can remodel these methylation patterns by counteracting ROS and supporting TET function, potentially reducing exposure-related epigenetic toxicity.[90]

References

User Avatar
No comments yet.